Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Miravitlles (Barcelona, Spain). Efficacy and safety of antibiotic treatment of stable COPD. Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations

Member's Comments

No comment yet.

Related content which might interest you: Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010 Indacaterol provides effective bronchodilation in patients with COPD regardless of concomitant ICS use Source: Annual Congress 2010 - Bronchodilators in airways disease Year: 2010 Doxofylline: Efficacy and safety in complex treatment of COPD Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Long-term treatment of aspirin-intolerante asthma with budesonide. Effectivity and safety Source: Eur Respir J 2001; 18: Suppl. 33, 156s Year: 2001 Evaluating the efficacy of chronic therapy with tiotropium in COPD through discontinuation of treatment Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002 Efficacy, safety and tolerability of 3 day azithromycin versus 10-day amoxillin/clavulanic acid in the treatment of children with pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 143s Year: 2003 Improvement of asthma control by a concomitant therapy with cineole Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments? Year: 2011 Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Safety and tolerability of indacaterol over 52 weeks of treatment in COPD Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009 Comparison of efficacy and safety of twice-daily Glycopyrronium/Formoterol combination with once-daily Glycopyrronium in patients with moderate to severe COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Cardiovascular safety of long-term therapy with combination bronchodilator in patients with stable COPD Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 Efficacy and tolerability of aclidinium bromide/formoterol fumarate fixed-dose combination in patients with COPD: A 1-year study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Assessment of efficacy and tolerability of roflumilast add-on to LABA/LAMA/ICS in the treatment of COPD in Indian patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 LABA/LAMA combinations efficacy evaluation therapy of COPD patients with emphasized morning and night symptoms Source: International Congress 2018 – COPD management Year: 2018 Efficacy and safety of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011 Fluticasone propionate/formoterol fumarate combination therapy has an efficacy and safety profile similar to that of its individual components administered concurrently in the treatment of asthma Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010 Efficacy and safety of indacaterol 150 μg once-daily in COPD: a 12-week study Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009